# The Efficacy and Safety Study of Tung's Acupuncture for Polycystic Ovarian Syndrome

> **NCT02729545** · PHASE2 · COMPLETED · sponsor: **Beijing Hospital of Integrated Traditional Chinese and Western Medicine** · enrollment: 60 (actual)

## Conditions studied

- Polycystic Ovarian Syndrome

## Interventions

- **OTHER:** Tung's acupuncture
- **DRUG:** Cyproterone acetate/ethinylestradiol (CPA/EE)

## Key facts

- **NCT ID:** NCT02729545
- **Lead sponsor:** Beijing Hospital of Integrated Traditional Chinese and Western Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-04
- **Primary completion:** 2018-03
- **Final completion:** 2018-05
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2019-10-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02729545

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02729545, "The Efficacy and Safety Study of Tung's Acupuncture for Polycystic Ovarian Syndrome". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02729545. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*